Trials / Not Yet Recruiting
Not Yet RecruitingNCT06889363
Clinical and Radiographic Evaluation of Indirect Pulp Capping Using Platelet Rich Fibrin Versus Mineral Trioxide Aggregate in Deep Carious Molars: a Randomized Controlled Trial
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is the clinical and radiographic evaluation of (Platelet-Rich Fibrin (PRF) versus Mineral Trioxide Aggregate (MTA) in indirect pulp capping when used with deep carious molars over 1 year follow up.
Detailed description
-PICOTS : P: Asymptomatic deep carious molars. I: Indirect pulp capping using PRF. C: Indirect pulp capping using MTA. O: Outcome name Measuring device Measuring unit Primary outcome: clinical findings : Pulp sensibility using cold test (Sharma A et al., 2020). Secondary outcome: Radiographic findings :Dentin bridge measurement in mm using digital radiographic ruler Digital Periapical using paralleling technique (Sharma A et al., 2020). T: T0: Baseline T1: 3 months T2: 6 months T3: 12 months S: Randomized clinical trial. \- Research question: Will PRF provide comparable clinical and radiographic outcomes to MTA in indirect pulp capping when used in deep carious molars?
Conditions
- Dental Caries
- Pulp Caping
- Indirect Pulp Treatment
- Indirect Pulp Cap
- Indirect Pulp Capping
- Indirect Pulp Therapy
- Deep Carious Lesion
- Deep Carious Lesions
- Molar Caries
- Carious Molars
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MTA | The indirect pulp capping will be applied using MTA using an MTA carrier, then glass ionomer will be applied, then composite restoration above |
| BIOLOGICAL | PRF | The indirect pulp capping will be applied using PRF on a membrane, then glass ionomer will be applied , then composite restoration above |
Timeline
- Start date
- 2025-06-01
- Primary completion
- 2026-09-01
- Completion
- 2026-09-01
- First posted
- 2025-03-21
- Last updated
- 2025-03-21
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06889363. Inclusion in this directory is not an endorsement.